Treating metastatic cancer with nanotechnology

A Schroeder, DA Heller, MM Winslow… - Nature Reviews …, 2012 - nature.com
Metastasis accounts for the vast majority of cancer deaths. The unique challenges for
treating metastases include their small size, high multiplicity and dispersion to diverse organ …

Polymersome-based drug-delivery strategies for cancer therapeutics

T Anajafi, S Mallik - Therapeutic delivery, 2015 - Taylor & Francis
Polymersomes are stable vesicles prepared from amphiphilic polymers and are more stable
compared with liposomes. Although these nanovesicles have many attractive properties for …

The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus

R Adam, A De Gramont, J Figueras, A Guthrie… - The …, 2012 - academic.oup.com
An international panel of multidisciplinary experts convened to develop recommendations
for the management of patients with liver metastases from colorectal cancer (CRC). The aim …

Near-Infrared Fluorescent Probe Activated by Nitroreductase for In Vitro and In Vivo Hypoxic Tumor Detection

S Karan, MY Cho, H Lee, H Lee, HS Park… - Journal of medicinal …, 2021 - ACS Publications
Tumor hypoxia is correlated with increased resistance to chemotherapy and poor overall
prognoses across a number of cancer types. We present here a cancer cell-selective and …

Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil

MM El-Hammadi, ÁV Delgado, C Melguizo… - International journal of …, 2017 - Elsevier
Fluorouracil (5-FU) is a broad spectrum cytotoxic agent being used in chemotherapy of
malignancies. However, 5-FU shows a number of limitations like short half-life, non-selective …

[HTML][HTML] Folate receptor as a biomarker and therapeutic target in solid tumors

O Young, N Ngo, L Lin, L Stanbery, JF Creeden… - Current Problems in …, 2023 - Elsevier
Folate is a B vitamin necessary for basic biological functions, including rapid cell turnover
occurring in cancer cell proliferation. Though the role of folate as a causative versus …

Delivery of oxaliplatin to colorectal cancer cells by folate-targeted UiO-66-NH2

A Hashemzadeh, F Amerizadeh, F Asgharzadeh… - Toxicology and Applied …, 2021 - Elsevier
Oxaliplatin is being used in different malignancies and several side effects are reported for
patients taking Oxaliplatin, including peripheral neuropathy, nausea and vomiting, diarrhea …

[HTML][HTML] Characterization of the human folate receptor alpha via novel antibody-based probes

DJ O'Shannessy, EB Somers, E Albone, X Cheng… - Oncotarget, 2011 - ncbi.nlm.nih.gov
Folate receptor alpha (FRA) is a cell surface protein whose aberrant expression in malignant
cells has resulted in its pursuit as a therapeutic target and marker for diagnosis of cancer …

Fluorescence molecular targeting of colon cancer to visualize the invisible

TM Lwin, MA Turner, S Amirfakhri, H Nishino… - Cells, 2022 - mdpi.com
Colorectal cancer (CRC) is a common cause of cancer and cancer-related death. Surgery is
the only curative modality. Fluorescence-enhanced visualization of CRC with targeted …

Prospects in folate receptor-targeted radionuclide therapy

C Müller, R Schibli - Frontiers in oncology, 2013 - frontiersin.org
Targeted radionuclide therapy is based on systemic application of particle-emitting
radiopharmaceuticals which are directed toward a specific tumor-associated target …